×

本司产品仅用于科研,不用于临床诊断和治疗

全国免费热线:400-999-2100

您身边的细胞培养专家!

所有分类
  • 所有分类
  • 细胞系
  • 原代细胞
  • 血清
  • 细胞培养基
  • 辅助试剂
  • 细胞凋亡检测试剂盒
  • 细胞房除菌产品
热搜: 胎牛血清 VERO RAW264.7 成纤维细胞 间充质干细胞 上皮细胞

忘记密码

个人邮箱:
验证码: captcha

账号激活

个人邮箱:
×
当前位置:首页 >> 产品中心 >> 细胞资源库 >> 细胞系 >> 

产品中心Cell Resources

联系我们CONTACT US

  • BT-20 (人乳腺癌细胞) (STR鉴定正确)
  • BT-20 (人乳腺癌细胞) (STR鉴定正确)
  • BT-20 (人乳腺癌细胞) (STR鉴定正确)
  • BT-20 (人乳腺癌细胞) (STR鉴定正确)
  • BT-20 (人乳腺癌细胞) (STR鉴定正确)
  • BT-20 (人乳腺癌细胞) (STR鉴定正确)
  • BT-20 (人乳腺癌细胞) (STR鉴定正确)

BT-20 (人乳腺癌细胞) (STR鉴定正确)

货号:CL-0324

规格:1×10⁶cells/T25培养瓶

价格: ¥1500

生长培养基:MEM(含NEAA)10% FBS1% P/S

数量: - +

  • BT-20 (人乳腺癌细胞) (STR鉴定正确)
  • BT-20 (人乳腺癌细胞) (STR鉴定正确)
  • BT-20 (人乳腺癌细胞) (STR鉴定正确)
  • BT-20 (人乳腺癌细胞) (STR鉴定正确)
  • BT-20 (人乳腺癌细胞) (STR鉴定正确)
  • BT-20 (人乳腺癌细胞) (STR鉴定正确)
  • BT-20 (人乳腺癌细胞) (STR鉴定正确)

推荐搭配

套餐1:

BT-20 (人乳腺癌细胞) (STR鉴定正确) ¥1500
BT-20细胞专用培养基
  • ¥350
  • ¥450

现单独购买该产品也可享受限时优惠价!

细胞培养最优解!

套餐组合价:¥1850¥1950

加入购物车

搭配套餐已成功加入购物车!

产品概述
产品信息
名称 BT-20 (人乳腺癌细胞) (STR鉴定正确)
别称 BT 20; BT20
种属
生长特性 贴壁细胞
细胞形态 上皮细胞样
冻存条件 冻存液:55% 基础培养基+40%FBS+5%DMSO 温度:液氮
培养方案A(默认)
生长培养基:
培养条件:
气相:空气,95%;CO2,5%, 温度:37℃
推荐传代比例 1:2-1:4
推荐换液频率 2-3次/周
参考资料(来源文献)
背景描述 BT-20细胞是由E·Y·Lasfargues和L·Ozzello于1958年建系,源自一位74岁白人女性的乳腺癌组织。BT-20细胞表达WNT3和WNT78;TNF-α抑制BT-20细胞生长。BT-20细胞雌激素受体阴性,但表达5'-外显子缺失的雌激素mRNA。
年龄(性别) 女性;74岁
组织来源 乳腺;侵袭性导管癌
细胞类型 肿瘤细胞
肿瘤类型 乳腺癌细胞
生物安全等级 BSL-1
倍增时间 ~70 hours
致瘤性 Yes, in nude mice (The cells form grade II adenocarcinomas).
抗原表达情况 HLA A1, Bw16 (+/-)
保藏机构 ATCC; CRL-7912ATCC; HTB-19
STR鉴定
  • STR位点信息
    Amelogenin X
    CSF1PO 12
    D2S1338 19
    D3S1358 17
    D5S818 12
    D7S820 10
    D8S1179 12
    D13S317 11
    D16S539 11,14
    D18S51 17
    D19S433 15
    D21S11 28,29
    FGA 22,24
    PentaD 10,11
    PentaE 11,13
    TH01 7,9.3
    TPOX 11
    vWA 16,17
    D6S1043 19
    D12S391 18.3,24
    D2S441 10,14
  • STR鉴定图
参考文献
文献列表
  • The dePARylase NUDT16 promotes radiation resistance of cancer cells by blocking SETD3 for degradation via reversing its ADP-ribosylation (2024-01-22)

    作者:Weijun Wu:1.Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China; Department of Oncology Radiotherapy, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China. ; Wenjing Wu:1.Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China; Department of Breast Oncology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China. ; Yingshi Zhou:1.Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, G

    期刊:The dePARylase NUDT16 promotes radiation resistance of cancer cells by blocking SETD3 for degradation via reversing its ADP-ribosylation

    DOI:10.1016/j.jbc.2024.105671

    影响因子 :4.8

    引用产品: MCF 10A 细胞 ,  HCC1806 细胞 ,  HCC1937 细胞 ,  MDA-MB-468 细胞 ,  BT-20 细胞 ,  Hs 578T 细胞 ,  MDA-MB-436 细胞 ,  MCF 10A细胞专用培养基 ,  HCC1806细胞专用培养基 ,  HCC1937细胞专用培养基 ,  MDA-MB-468细胞专用培养基 (L15) ,  BT-20细胞专用培养基 ,  Hs 578T细胞专用培养基 ,  MDA-MB-436细胞专用培养基 (L15)

  • LINC01234 promoted malignant behaviors of breast cancer cells via hsa-miR-30c-2-3p/CCT4/mTOR signaling pathway (2024-01-11)

    作者:Chuangang Tang:1.Suzhou Medical College of Soochow University, Suzhou, Jiangsu, 215123, China; Department of Breast Surgery, Xuzhou Central Hospital, Postgraduate Workstation of Soochow University Xuzhou, Jiangsu, 221009, China. ; Changwen Li:1.Department of Breast Surgery, Xuzhou Central Hospital, Jiangsu, 221009, China. ; Chengling Chen:1.Department of Breast Surgery, Xuzhou Central Hospital, Jiangsu, 221009, China. ; Tao Chen:1.The Xuzhou Clinical College of Xuzhou Medical University, Jiangsu, 221009, China. ; Juan Zhu:1.Department of Breast Surgery, Xuzhou Central Hospital, Jiangsu, 221009, China. ; Mingyu Sun:1.Department of Breast Surgery, Xuzhou Central Hospital, Jiangsu, 221009, China. Electronic address: 645396517@qq.com. ; Pei Wang:1.Department of Breast Surgery, Xuzhou Central Hospital, Jiangsu, 221009, China. Electronic address: 1349533289@qq.com. ; Conghui Han:1.Suzhou Medical College of Soochow University, Suzhou, Jiangsu, 215123, China; Department of Urology, Xuzh

    期刊:LINC01234 promoted malignant behaviors of breast cancer cells via hsa-miR-30c-2-3p/CCT4/mTOR signaling pathway

    DOI:10.1016/j.tjog.2023.09.019

    影响因子 :2.1

    引用产品: BT-20 细胞

  • Leveraging senescence-oxidative stress co-relation to predict prognosis and drug sensitivity in breast invasive carcinoma (2023-08-04)

    作者:Yinghui Ye:1.Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, China. ; Yulou Luo:1.Department of Breast Surgery, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, China. ; Tong Guo:1.Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, China. ; Chenguang Zhang:1.Department of Breast Surgery, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, China. ; Yutian Sun:1.Department of Medical Oncology, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China. ; Anping Xu:1.Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, China. ; Ling Ji:1.Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, China. ; Jianghua Ou:1.Department of Breast Surgery, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, China. ; Shang Ying Wu:1.Depa

    期刊:Leveraging senescence-oxidative stress co-relation to predict prognosis and drug sensitivity in breast invasive carcinoma

    DOI:10.3389/fendo.2023.1179050

    影响因子 :5.2

    引用产品: MCF7 [MCF-7] 细胞 ,  BT-20 细胞 ,  MDA-MB-231 细胞 ,  HCC1806 细胞 ,  HCC1937 细胞 ,  MCF7 [MCF-7]细胞专用培养基 ,  BT-20细胞专用培养基 ,  MDA-MB-231细胞专用培养基 (L15) ,  HCC1806细胞专用培养基 ,  HCC1937细胞专用培养基

  • Gankyrin inhibits ferroptosis through the p53/SLC7A11/GPX4 axis in triple-negative breast cancer cells (2023-12-08)

    作者:Ming Lei:1.Department of Breast and Thyroid Surgery, The Second Affiliated Hospital, Hainan Medical University, Haikou, 570311, China. ; 2.Key Laboratory of Tropical Translational Medicine of Ministry of Education & School of Tropical Medicine, Hainan Medical University, Haikou, 571199, China. ; Yun-Long Zhang:1.Key Laboratory of Tropical Translational Medicine of Ministry of Education & School of Tropical Medicine, Hainan Medical University, Haikou, 571199, China. ; Feng-Ying Huang:1.Key Laboratory of Tropical Translational Medicine of Ministry of Education & School of Tropical Medicine, Hainan Medical University, Haikou, 571199, China. ; Heng-Yu Chen:1.Department of Breast and Thyroid Surgery, The Second Affiliated Hospital, Hainan Medical University, Haikou, 570311, China. ; Ming-Hui Chen:1.Key Laboratory of Tropical Translational Medicine of Ministry of Education & School of Tropical Medicine, Hainan Medical University, Haikou, 571199, China. ; Ri-Hong Wu:1.Key Laboratory of T

    期刊:Gankyrin inhibits ferroptosis through the p53/SLC7A11/GPX4 axis in triple-negative breast cancer cells

    DOI:10.1038/s41598-023-49136-8

    影响因子 :4.6

    引用产品: MDA-MB-231 细胞 ,  HCC1937 细胞 ,  MDA-MB-468 细胞 ,  BT-20 细胞 ,  Hs 578T 细胞 ,  MCF 10A 细胞

  • Prognosis stratification of patients with breast invasive carcinoma based on cysteine metabolism-disulfidptosis affinity (2023-07-08)

    作者:Yuting Zhang:1.Department of Breast Surgery, The First Affiliated Hospital, Jinan University, Guangzhou, 510000, China. ; Yinghui Ye:1.Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, 518000, China. ; Anping Xu:1.Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, 518000, China. ; Yulou Luo:1.Department of Breast Surgery, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, 830000, China. ; Yutian Sun:1.Department of Medical Oncology, School of Medicine, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, 610000, China. ; Wei Zhang:1.Department of Breast Surgery, The First Affiliated Hospital, Jinan University, Guangzhou, 510000, China. zhangwei@jnu.edu.cn. ; Ling Ji:1.Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, 518000, China. 1120303921@qq.com. ;

    期刊:Prognosis stratification of patients with breast invasive carcinoma based on cysteine metabolism-disulfidptosis affinity

    DOI:10.1007/s00432-023-05028-y

    影响因子 :3.6

    引用产品: MCF7 [MCF-7] 细胞 ,  MCF7 [MCF-7]细胞专用培养基 ,  BT-20 细胞 ,  BT-20细胞专用培养基 ,  MDA-MB-231 细胞 ,  MDA-MB-231细胞专用培养基 (L15) ,  MDA-kb2 细胞 ,  MDA-kb2细胞专用培养基 (L15) ,  HCC1937 细胞 ,  HCC1937细胞专用培养基

  • EXOSC2 Mediates the Pro-tumor Role of WTAP in Breast Cancer Cells via Activating the Wnt/β-Catenin Signal (2023-10-19)

    作者:Chen-Guang Lv:1.Department of General Surgery, General Hospital of Northern Theater Command, Shenyang, People's Republic of China. ; Yao Cheng:1.Department of Oncology, Panjin Central Hospital, Panjin, People's Republic of China. ; Lei Zhang:1.Department of Breast Surgery, The First Hospital of China Medical University, No. 155, Nanjing North Street, Shenyang, People's Republic of China. ; Guo-Gang Wu:1.Department of Thyroid and Breast Surgery, Ansteel Group General Hospital, Anshan, People's Republic of China. ; Chun-Yan Liang:1.Department of Oncology, The Fourth Affiliated Hospital of China Medical University, Shenyang, People's Republic of China. ; Zuo Tao:1.Department of General Surgery, General Hospital of Northern Theater Command, Shenyang, People's Republic of China. ; Bo Chen:1.Department of Breast Surgery, The First Hospital of China Medical University, No. 155, Nanjing North Street, Shenyang, People's Republic of China. chenbocmu@sina.com. ;

    期刊:EXOSC2 Mediates the Pro-tumor Role of WTAP in Breast Cancer Cells via Activating the Wnt/β-Catenin Signal

    DOI:10.1007/s12033-023-00834-8

    影响因子 :2.6

    引用产品: BT-20 细胞

  • The inhibition of centromere protein K causes anticancer effects in breast carcinoma via effects on the FAK/PI3K/AKT/mTOR pathway (2022-09-09)

    作者:Jiao Yu:1.Department of Radiation Oncology, Shaanxi Provincial People's Hospital, Xi'an 710068, China. ; Kai Wang:1.Department of Traditional Chinese Medicine, Xi'an Chang'an District Hospital, Xi'an 710119, China. ; Sanhu Yang:1.Department of Thoracic Surgery, Tangdu Hospital, Air Force Military Medical University, Xi'an 710049, China. ; Gang Li:1.Department of Thyroid and Breast Surgery, Xi'an Daxing Hospital, Xi'an 710068, China. Electronic address: dooopenitlg@163.com. ;

    期刊:The inhibition of centromere protein K causes anticancer effects in breast carcinoma via effects on the FAK/PI3K/AKT/mTOR pathway

    DOI:10.1016/j.taap.2022.116232

    影响因子 :4.5

    引用产品: T-47D 细胞 ,  Hs 578T 细胞 ,  MCF7 [MCF-7] 细胞 ,  BT-20 细胞 ,  BT-549 细胞 ,  MCF 10A 细胞 ,  RPMI-1640 培养基 ,  MEM 培养基 ,  DMEM/F12 培养基

  • 点击展开收起列表
FAQs

Q:{{item.question}}

A:

暂无数据
产品资料
注:百度浏览器无法支持扫一扫功能,请输入识别码,获取相应产品资料

识别码示意图

确定
邱国娜/胡文君

邱国娜/胡文君

【 上海 】

何帆

何帆

【 陕西、甘肃、宁夏、青海、新疆 】

 熊经理

熊经理

【 海南 】

朱莎莉

朱莎莉

【 湖北 】

刘本佳

刘本佳

【江苏(除南京外)】

章臣雄

章臣雄

【 广州 】

杜焱炜

杜焱炜

【 四川、云南、西藏 】

田博浩

田博浩

【 重庆、贵州 】

石文平

石文平

【 北京、辽宁 】

胡文君

胡文君

【江西】

李荣枫

李荣枫

【 天津、河北、内蒙古、山西 】

陈雨兰

陈雨兰

【 山东 】

尹国文

尹国文

【浙江】

唐小花

唐小花

【 吉林、黑龙江 】

付帅

付帅

【 安徽 】

朱俊宇

朱俊宇

【 河南、广西 】

李庆祖

李庆祖

【 湖南 】

熊志亮

熊志亮

【 深圳 】

梅文强

梅文强

【福建】

林钊光

林钊光

【南京】

微信扫一扫咨询

微信扫一扫咨询

在线客服
关闭
在线咨询

关注微信公众号